Stockreport

GeoVax Partners with Allucent to Conduct Phase 2b Clinical Study of Next-Generation COVID-19 Vaccine Candidate with Funding from BARDA [Yahoo! Finance]

GeoVax Labs, Inc.  (GOVX) 
NASDAQ:AMEX Investor Relations: geovax.com/contact-geovax.html
PDF Study is Funded by BARDA through Project NextGen, executed through its Clinical Studies Network ATLANTA, GA - ( NewMediaWire ) - June 27, 2024 - GeoVax Labs, Inc. (Na [Read more]